Eimear Mylod

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2024
Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma.

Maria Davern, Cillian O' Donovan, Noel E Donlon

|Mar 29, 2023
Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma.

Fiona O'Connell, Eimear Mylod, Noel E Donlon

|Mar 27, 2023
Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis.

Laura E Kane, Gregory S Mellotte, Eimear Mylod

|Feb 25, 2023
Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses.

Jennifer Moran, Eimear Mylod, Laura E Kane

|Jan 11, 2022
The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism.

Eimear Mylod, Fiona O'Connell, Noel E Donlon

|Jul 29, 2021
Fractalkine Elicits Chemotactic, Phenotypic, and Functional Effects on CX3CR1+CD27- NK Cells in Obesity-Associated Cancer.

Eimear Mylod, Ashanty M Melo, Noel E Donlon

Pageof 1

Frequent Collaborators

4 joint publications

Noel E Donlon

4 joint publications

Joanne Lysaght

3 joint publications

Christine Butler

2 joint publications

Fiona O'Connell